about
Chlamydia pneumoniae and oxidative stress in cardiovascular disease: state of the art and prevention strategiesSynthesis and biological evaluation of 2-methoxy- and 2-methylthio-6-[2'-alkylamino)ethyl]-4(3H)-pyrimidinones with anti-rubella virus activity.Synthesis and biological evaluation of 4-alkylamino-6-(2-hydroxyethyl)-2-methylthiopyrimidines as new rubella virus inhibitors.Soluble products of Escherichia coli induce mitochondrial dysfunction-related sperm membrane lipid peroxidation which is prevented by lactobacilli.Correlation between lactoferrin and beneficial microbiota in breast milk and infant's feces.Administration of a multistrain probiotic product (VSL#3) to women in the perinatal period differentially affects breast milk beneficial microbiota in relation to mode of delivery.Effects of vaginal lactobacilli in Chlamydia trachomatis infection.Chemistry, stability and bioavailability of resveratrol.Resveratrol inhibits rhinovirus replication and expression of inflammatory mediators in nasal epithelia.Effect of polyelectrolytes on entry of Escherichia coli HB101 (pRI203) into HeLa cells.Electrostatic interactions in the early events of VSV infection.Improved stability of trans-resveratrol in aqueous solutions by carboxymethylated (1,3/1,6)-β-D-glucan.A new and efficient synthesis of substituted 6-[(2'-dialkylamino)ethyl] pyrimidine and 4-N,N-dialkyl-6-vinyl-cytosine derivatives and evaluation of their anti-rubella activity.Binding sites for rubella virus on erythrocyte membrane.Effect of polyions on the early events of Sindbis virus infection of Vero cells.Antiviral activity of Lactobacillus brevis towards herpes simplex virus type 2: role of cell wall associated components.Relationship between enzymatic modifications of serum low density lipoproteins and their haemagglutination inhibiting activity towards Sindbis virus.Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis.Evaluation of stool antigen test, PCR on ORAL samples and serology for the noninvasive detection of Helicobacter pylori infection in children.Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tabletsTechnological and biological evaluation of tablets containing different strains of lactobacilli for vaginal administrationDoes hospital work constitute a risk factor for Helicobacter pylori infection?Role of membrane phospholipids and glycolipids in cell-to-cell fusion by VSVInhibition of herpes simplex, rabies and rubella viruses by lectins with different specificitiesHelicobacter pylori infection among healthcare workers: further investigation is neededBiological effects of MC2050, a quinazoline-based PARP-1 inhibitor, in human neuroblastoma and EBV-positive Burkitt's lymphoma cellsEffectiveness of vaginal tablets containing lactobacilli versus pH tablets on vaginal health and inflammatory cytokines: a randomized, double-blind study
P50
Q27009367-0340B93F-6CCB-48BE-AA14-E6CB3FAA0CBCQ30583122-6B70C770-B7D2-4B32-86B0-AB8D3684882BQ33260579-6B8232DB-8BEE-4AE6-A177-0A028224D861Q35073009-8A86E7F1-9DA9-4B9E-B48A-C7BEEC7DE256Q35196087-E7EE3727-6CF9-47BB-B705-CE4823C56DB8Q35594223-9C8EAED6-E607-42BA-9C0E-2CF19E8B5FD6Q37844275-644B230C-ACE8-41BA-8B18-DA44178D4EE1Q38170513-296C0678-FD79-4A28-81F1-384C441DA521Q41039465-3D3A8C9E-D45E-4480-86F4-0709F78F8650Q41511164-AE6C56FD-6920-4CF8-BE49-D23EF3C29E38Q41709491-7EBB8EBC-9F36-4AF4-B6CE-2BD4FD7188FFQ42231032-AC8F52A9-10A1-4BDE-A9B8-9E7C1AEB7C97Q43976088-9758AD44-9A9C-4FED-B19A-2C9E8D969434Q44008244-92C5D752-AD1F-496E-932C-45D8F2198E6CQ45131745-8A73BFFC-FDCB-41B9-8007-67F32926D758Q45366135-44DD7B29-37AE-49F7-9476-908CFBF38885Q45791051-2F9274B7-E4DA-4420-A28B-BA75A0B35119Q47204855-D641C625-55E4-4DEF-9B87-77F0117CD3D5Q47445514-0B550DE0-BE7F-446A-BC43-800A82662410Q57417926-A9A084ED-1DFA-455C-9F48-D7F59D5756B0Q57417930-33E06DC8-9B32-4BF8-875A-DC3FBDE7EA0EQ64923194-2B176016-D01E-4217-A9F0-9988EF90F07BQ68266191-AAD451D1-2474-4741-ADDE-BD4FF8A0A9C7Q71540368-F82F5937-4CE8-49F0-A981-23E12ABEB839Q80508307-2ED83A90-1552-4478-9C7F-CDC48DEFF537Q83510539-F7E1878E-BA88-4644-8B96-9F4026A3B2D8Q84552653-0C97AD92-0145-4925-AB27-05BB901D59E9
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Paola Mastromarino
@ast
Paola Mastromarino
@en
Paola Mastromarino
@es
Paola Mastromarino
@nl
type
label
Paola Mastromarino
@ast
Paola Mastromarino
@en
Paola Mastromarino
@es
Paola Mastromarino
@nl
prefLabel
Paola Mastromarino
@ast
Paola Mastromarino
@en
Paola Mastromarino
@es
Paola Mastromarino
@nl
P106
P1153
55982889600
P21
P31
P496
0000-0002-8529-0216